Rincon-Gonzalez, Liliana http://orcid.org/0000-0002-5565-9609
Selig, Wendy K. D.
Hauber, Brett
Reed, Shelby D.
Tarver, Michelle E.
Chaudhuri, Shomesh E.
Lo, Andrew W.
Bruhn-Ding, Dean
Liden, Barry
Funding for this research was provided by:
U.S. Food and Drug Administration (HHSF223201810116C)
Article History
Received: 30 May 2022
Accepted: 12 August 2022
First Online: 27 August 2022
Declarations
:
: Shelby D. Reed works at the Duke Clinical Research Institute where she leads the PrefER group that specializes in stated-preference research. This group conducts research funded by government and industry sponsors. Shomesh E. Chaudhuri and Andrew W. Lo hold proprietary rights to the Bayesian Decision Analysis framework. Dean Bruhn-Ding is an employee and shareholder at CVRx. Barry Liden is an employee of the University of Southern California and shareholder at Edwards Lifesciences. Wendy K.D. Selig is founder and CEO of WSCollaborative, a consulting firm that works with non-profit and for-profit entities within the life sciences and served as a consultant to MDIC in support of the effort described in this manuscript. Brett Hauber is an employee of Pfizer, Inc., but was an employee of RTI Health Solutions at the time this manuscript was developed. All other authors have no relevant conflicts to disclose.